ArticleNature reviews. Clinical oncology2024

Pyrotinib in combination with first-line trastuzumab and docetaxel for patients with HER2-positive metastatic breast cancer: a new therapeutic option?

Pier Paolo M Berton Giachetti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.